A. Brito

Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity.

S. Forman, Christine E. Brown, D. Alizadeh, 2018, JCI insight.

Selective IL13Rα2-Targeted Functionality of IL13-Ligand CARs is Enhanced by Inclusion of 4-1BB Co-Stimulation

Leo D. Wang, B. Badie, S. Forman, 2022, bioRxiv.

Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.

B. Badie, M. D'Apuzzo, S. Forman, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Systemic Anti–PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid

B. Badie, S. Forman, Christine E. Brown, 2020, JAMA oncology.